These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36155191)

  • 1. Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications.
    Nagata N; Takeuchi T; Masuoka H; Aoki R; Ishikane M; Iwamoto N; Sugiyama M; Suda W; Nakanishi Y; Terada-Hirashima J; Kimura M; Nishijima T; Inooka H; Miyoshi-Akiyama T; Kojima Y; Shimokawa C; Hisaeda H; Zhang F; Yeoh YK; Ng SC; Uemura N; Itoi T; Mizokami M; Kawai T; Sugiyama H; Ohmagari N; Ohno H
    Gastroenterology; 2023 Feb; 164(2):272-288. PubMed ID: 36155191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites.
    Zhang D; Weng S; Xia C; Ren Y; Liu Z; Xu Y; Yang X; Wu R; Peng L; Sun L; Zhu J; Liang X; Jia Y; Wang H; Chen Q; Liu D; Chen Y; Guo H; Han X; Jin Z; Chen C; Yang X; Li Z; Huang H
    BMC Med; 2023 Jul; 21(1):264. PubMed ID: 37468867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
    Albrich WC; Ghosh TS; Ahearn-Ford S; Mikaeloff F; Lunjani N; Forde B; Suh N; Kleger GR; Pietsch U; Frischknecht M; Garzoni C; Forlenza R; Horgan M; Sadlier C; Negro TR; Pugin J; Wozniak H; Cerny A; Neogi U; O'Toole PW; O'Mahony L
    Gut Microbes; 2022; 14(1):2073131. PubMed ID: 35574937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of gut microbes and host's immune response in gut-lung homeostasis.
    Rastogi S; Mohanty S; Sharma S; Tripathi P
    Front Immunol; 2022; 13():954339. PubMed ID: 36275735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metagenomic assessment of gut microbial communities and risk of severe COVID-19.
    Nguyen LH; Okin D; Drew DA; Battista VM; Jesudasen SJ; Kuntz TM; Bhosle A; Thompson KN; Reinicke T; Lo CH; Woo JE; Caraballo A; Berra L; Vieira J; Huang CY; Das Adhikari U; Kim M; Sui HY; Magicheva-Gupta M; McIver L; Goldberg MB; Kwon DS; Huttenhower C; Chan AT; Lai PS
    Genome Med; 2023 Jul; 15(1):49. PubMed ID: 37438797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
    Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
    Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
    Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
    World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Gut Microbiota with Inflammatory Bowel Disease and COVID-19 Severity: A Possible Outcome of the Altered Immune Response.
    Kaushal A; Noor R
    Curr Microbiol; 2022 May; 79(6):184. PubMed ID: 35508737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes.
    Lv L; Jiang H; Chen Y; Gu S; Xia J; Zhang H; Lu Y; Yan R; Li L
    Anal Chim Acta; 2021 Apr; 1152():338267. PubMed ID: 33648648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiome and Cytokine Profiles in Post-COVID Syndrome.
    Mussabay K; Kozhakhmetov S; Dusmagambetov M; Mynzhanova A; Nurgaziyev M; Jarmukhanov Z; Vinogradova E; Dusmagambetova A; Daulbaeva A; Chulenbayeva L; Tauekelova A; Bekbossynova M; Kushugulova A
    Viruses; 2024 May; 16(5):. PubMed ID: 38793604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivotal interplays between fecal metabolome and gut microbiome reveal functional signatures in cerebral ischemic stroke.
    Zhao L; Wang C; Peng S; Zhu X; Zhang Z; Zhao Y; Zhang J; Zhao G; Zhang T; Heng X; Zhang L
    J Transl Med; 2022 Oct; 20(1):459. PubMed ID: 36209079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis.
    Guo M; Wu G; Tan Y; Li Y; Jin X; Qi W; Guo X; Zhang C; Zhu Z; Zhao L
    mBio; 2023 Feb; 14(1):e0351922. PubMed ID: 36744910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis reveals the associations between altered gut microbiota, metabolites, and cytokines during pregnancy.
    Huang T; Liang X; Bao H; Ma G; Tang X; Luo H; Xiao X
    mSystems; 2024 Mar; 9(3):e0125223. PubMed ID: 38323818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of gut microbiome and host immune responses in COVID-19.
    Xu X; Zhang W; Guo M; Xiao C; Fu Z; Yu S; Jiang L; Wang S; Ling Y; Liu F; Tan Y; Chen S
    Front Med; 2022 Apr; 16(2):263-275. PubMed ID: 35258762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.